Integrated Treatment Program for Hypochondriasis in Primary Care Settings

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

91 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-05-31

Study Completion Date

2008-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate the effectiveness of an integrated three-part treatment program in improving the quality of care and treatment outcomes of people with hypochondriasis in primary care settings.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pragmatic Collaborative Care for Cardiac Inpatients With Depression or Anxiety

NCT03118752

Acute Coronary Syndrome Heart Failure Depression +2 more

COMPLETED NA

Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders

NCT01243606

Anxiety Disorders Mood Disorders

COMPLETED NA

Online Treatments for Mood and Anxiety Disorders in Primary Care

NCT01482806

Depression Generalized Anxiety Disorder Panic Disorder

COMPLETED PHASE2/PHASE3

Integrating Solution Focused Interventions in Integrated Care

NCT05838222

Depression Diabetes Mellitus Hypertension +1 more

COMPLETED NA

Using Telehealth to Improve Psychiatric Symptom Management

NCT02710344

Mental Disorders

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hypochondriasis, which is classified as a type of somatoform disorder, is one of the most difficult psychiatric disorders to treat. It is prevalent in primary care settings, and is a major source of suffering for patients and frustration for physicians. People with hypochondriasis tend to become preoccupied with the fear of having a serious disease, despite appropriate medical evaluations and reassurance that indicate otherwise. The disorder usually occurs in episodes lasting from months to years, separated by equally long periods of quiescence. Existing strategies for treating hypochondriasis include psychotherapy, medication treatment, and alternative treatments, such as exercise and electroconvulsive therapy. An effective treatment program should target the needs of both patients and physicians, as well as the structure of the delivery system. Components of such a program have been developed, but have not yet been integrated and tested in a clinical setting. This study will evaluate the effectiveness of an integrated three-part treatment program in improving hypochondriasis treatment and quality of care outcome in primary care settings.

Participants in this 6-month, single-blind study will first undergo baseline assessments. They will then be randomly assigned to partake in either the three-part treatment program or relaxation response training, in which patients are taught to use muscle relaxation techniques to reduce stress. Over the course of the study, participants assigned to the three-part program will attend five self-scheduled, 30-minute sessions of psychoeducational counseling based on cognitive behavioral therapy principles. Sessions will focus on common hypochondriacal cognitive distortions and misunderstandings about symptoms, disease, and medical care. Additionally, the doctors and nurses at the participating hospital will undergo a training program to improve medical management of patients with hypochondriasis. The final component of the program will entail implementing an enhanced role for nurse practitioners to collaborate with primary care physicians in caring for patients with hypochondriasis. Participants assigned to relaxation response training will attend three self-scheduled, 1-hour sessions over the course of the study. They will be provided with an explanation of the physical effects of stress on the body and the purposes of progressive muscle relaxation training. They will then learn a relaxation technique through direct instruction, and will practice between sessions. Participants will also use a 20-minute audio tape to practice once a day, 5 to 7 days a week between clinic visits. All participants will attend self-scheduled follow-up visits 6 and 12 months following the end of treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypochondriasis Somatoform Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Participants will receive psychoeducational counseling (termed "health care counseling")

Group Type EXPERIMENTAL

Psychoeducational counseling

Intervention Type BEHAVIORAL

Patients will receive five sessions of psychoeducational counseling from the nurse who works with the primary care physicians. Patients who are interested in continuing treatment or who have not responded to this first treatment step will then be referred for the second step, cognitive behavioral therapy (CBT), for more intensive treatment.

2

Participants will receive relaxation response training

Group Type ACTIVE_COMPARATOR

Relaxation response training

Intervention Type BEHAVIORAL

The control treatment is relaxation training or attention control. This will be taught in three, 1-hour sessions with a trained therapist.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Relaxation response training

The control treatment is relaxation training or attention control. This will be taught in three, 1-hour sessions with a trained therapist.

Intervention Type BEHAVIORAL

Psychoeducational counseling

Patients will receive five sessions of psychoeducational counseling from the nurse who works with the primary care physicians. Patients who are interested in continuing treatment or who have not responded to this first treatment step will then be referred for the second step, cognitive behavioral therapy (CBT), for more intensive treatment.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Relaxation and Stress Reduction Educational Counseling

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Has received primary medical care at Harvard Vanguard Medical Associates (HVMA) for at least 12 months prior to study entry
* Expects to continue receiving care from the current primary care physician for at least the next 12 months
* Meets requirement for average hypochondriasis screening score
* Able to speak and read English
* Falls within the top 20% of utilizers of health care services in the HVMA system over the past year
* Has attended no more than one visit to any specialist over the year prior to study entry

Exclusion Criteria

* Psychiatric illness (e.g., psychosis, dementia, suicidal ideation)
* Somatoform pain disorder or currently receiving treatment for somatoform pain disorder (e.g., relaxation training)
* History of alcohol or substance abuse or dependence within the 12 months prior to study entry
* Terminal medical illness or major medical illness expected to worsen significantly over the next year
* Ongoing symptom-contingent litigation against HVMA
* Monetary compensation for medical disability

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No